Dr. Monde Muyoyeta joins CIDRZ from ZAMBART where she served as Head of Diagnostic Studies and spent over nine years designing and conducting field epidemiological and laboratory studies. She holds Bachelor degrees in Human Biology, Medicine and Surgery from the University of Zambia, and a PhD in Infectious Disease Epidemiology from The London School of Hygiene and Tropical Medicine, University of London, U.K.
While at ZAMBART Dr Muyoyeta held several key positions including Investigator in the ZAMSTAR study, a large, two-country randomized control trial of community-level interventions aimed at reducing the burden of TB and HIV. She is also an Investigator on the AERAS TB vaccine trial, and has led studies evaluating computer-aided TB diagnosis using digital radiography and field evaluations of Xpert MTB/RIF, a new TB diagnostic technology. Her research interests include implementation and evaluation of new diagnostic technologies specifically in patients with both TB and HIV, and for TB control and prevention.